The Association Between CBT-I Dose, Sleep Duration, & Fatigue in Breast

Status Recruiting

Clinical Trial Summary

Cancer-related fatigue (CRF) and insomnia are prevalent among cancer patients and have been linked to de-creases in quality of life and poorer overall survivorship. Currently, the mechanisms underlying CRF are not well understood, which has led to treatments that are only moderately effective. In addition, when compared to CBT-I in the general population, the treatment outcomes in CBT-I with cancer patients are subpar and, as such, this study will evaluate whether dose of CBT-I is effective in ameliorating CRF.

Clinical Trial Description

Subjects will be randomized into one of four groups, four, eight, ten or twelve sessions. Sessions will be con-ducted weekly by Telehealth and will be modified based on the duration of treatment but all will include the following, evaluation and orientation; data acquisition and delivery of sleep restriction therapy & stimulus control instructions; review of sleep hygiene; cognitive therapy [decatastrophization]; managing non-adherence and relapse prevention), and, finally, the final sessions will be largely focused on time-in-bed titration. Treatment will be conducted by a master therapist via a HIPAA compliant video link. All CBT-I related data will be obtained via dedicated internet websites built with RedCap, where subjects will be asked to complete weekly and monthly questionnaires. One website will be for use by subjects. One website will be for use by the therapist. The patient and therapist website will have a landing page (password entry), a login page, and an activities page (what questionnaires are due when). For an example of such a website, please see our pilot study, https://redcap.med.upenn.edu/surveys/?s=RXLLA7C4KJ (access using password "sleepstudy"). The patient website will contain daily sleep diaries, weekly severity measures of insomnia (ISI), sleepiness (ESS), fatigue (PROMIS 7a, Brief Fatigue Inventory, and FACIT-F), depression (PHQ-9), anxiety (GAD-7), a medical symptoms checklist. ;

Study Design

Related Conditions & MeSH terms

Cancer-related Problem/Condition
Cancer-Related Syndrome
Chronic Insomnia
Fatigue
Neoplasms
Sleep Initiation and Maintenance Disorders

Clinical Trial Details

NCT number	NCT05226078
Study type	Interventional
Source	Abramson Cancer Center at Penn Medicine
Contact	Alexandria Muench
Phone	215-746-4378
Email	amuench@pennmedicine.upenn.edu
Status	Recruiting
Phase	N/A
Start date	March 1, 2023
Completion date	September 30, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03171519` - Effects of Exercise and Acupuncture on Chronic Insomnia	N/A
Completed	`NCT02515006` - Impact of Homeopathy for Persistent Insomnia in Patients With Cancer	N/A
Recruiting	`NCT05247697` - Mirtazapine for Chronic Insomnia in Older Adults	Phase 1
Active, not recruiting	`NCT04350866` - Enhancing Access to Insomnia Care in VA PCMHI Clinics
Active, not recruiting	`NCT04366284` - Optimizing the Scalability of Evidence-Based Behavioral Sleep Medicine Practices With a Digital Health Platform	N/A
Recruiting	`NCT04761796` - Sleep Time and Insomnia Factors Among Professional Flight Members
Completed	`NCT02688569` - Sleep and Pain Intervention for Chronic Widespread Pain Pilot Study	N/A
Completed	`NCT02236845` - Pilot Study to Clinical Evaluate Lacrima Medical Device in Insomnia Patients	N/A
Completed	`NCT01949389` - Piloting an Internet-based Therapy for Insomnia in a Population of Veterans With Substance Use Disorders	N/A
Completed	`NCT00414102` - Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia.	Phase 4
Completed	`NCT00671294` - Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia.	Phase 3
Completed	`NCT02392000` - Mobile Sleep Intervention for OEF, OIF and OND Veterans	N/A
Recruiting	`NCT04471168` - Interest of Auriculotherapy in the Management of Chronic Insomnia	N/A
Completed	`NCT02774642` - Integrated CBT-I and PE on Sleep and PTSD Outcomes (Impact Study)	N/A
Completed	`NCT02290405` - Impact of Hyperarousal on Simple and Complex Cognitive Task Performance Among Insomnia Sufferers
Recruiting	`NCT05618002` - Lemborexant vs Zopiclone vs Clonidine for Insomnia Treatment in Chronic Pain Patients
Completed	`NCT01995838` - A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Bayesian Adaptive Randomization Design, Dose Response Study of the Efficacy of E2006 in Adults and Elderly Subjects With Chronic Insomnia	Phase 2
Recruiting	`NCT05457790` - Feasibility and Preliminary Efficacy of Acceptance and Commitment Therapy (ACT) for Sleep Disturbances in Adults With Sickle Cell Disease (SCD)	N/A
Active, not recruiting	`NCT02272712` - The Effectiveness of Online Treatment for Insomnia in Cancer Survivors	N/A
Completed	`NCT00915135` - Efficacy and Safety of Ramelteon on Chronic Insomnia	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms